Cell reports · 2025
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Morris Daniel J, Gorman Jason, Zhou Tongqing, Lora Jinery, Connell Andrew J, Li Hui, Liu Weimin, Roark Ryan S, Campion Mary S, Carey John W, Habib Rumi, Li Yingying, Martella Christian L, Park Younghoon, Singh Ajay, Sowers Kirsten J, Teng I-Ting, Wang Shuyi, Chohan Neha, Ding Wenge, Lauer Craig, Lewis Emily, Mason Rosemarie D, Rando Juliette M, Peyton Lowrey, Schramm Chaim A, Wagh Kshitij, Korber Bette, Seaman Michael S, Douek Daniel C, Haynes Barton F, Kulp Daniel W, Roederer Mario, Hahn Beatrice H, Kwong Peter D, Shaw George M
Аннотация
Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 CD4-binding site (CD4bs) occur infrequently in macaques and humans and have not been reproducibly elicited in any outbred animal model. To address this challenge, we first isolated RHA10, an infection-induced rhesus bNAb with 51% breadth. The cryoelectron microscopy (cryo-EM) structure of RHA10 with the HIV-1 envelope (Env) resembled prototypic human CD4bs bNAbs with CDR-H3-dominated binding. Env-antibody co-evolution revealed transient elimination of two Env CD4bs-proximal glycans near the time of RHA10-lineage initiation, and these glycan-deficient Envs bound preferentially to early RHA10 intermediates, suggesting that glycan deletions in infecting SHIVs could induce CD4bs bNAbs. To test this hypothesis, we constructed SHIV.CH505 variants with CD4bs-proximal glycan deletions. Infection of 11 macaques resulted in accelerated CD4bs bNAb responses in 9 compared with 1 of 115 control macaques. Glycan hole-based immunofocusing coupled to Env-Ab co-evolution can consistently induce broad CD4bs responses in macaques and serve as a model for HIV vaccine design.